Catalyst (CPRX) Soars 16.7%: Is Further Upside Left in the Stock?

Catalyst Pharmaceutical (CPRX) shares rallied 16.7% in the last trading session to close at $22.80. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 11.7% loss over the past four weeks.The sudden rise in the stock price was observed after Catalyst, along with its licensor, SERB, announced that it has entered into a settlement agreement with Teva Pharmaceuticals regarding the Firdapse (amifampridine) patent lit ...